|
|
|
|
| LEADER |
01000cas a22002652 4500 |
| 001 |
DOAJ000151440 |
| 003 |
DE-627 |
| 005 |
20240412065922.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
230225c20229999xx u| |o 0 |0eng c |
| 022 |
|
|
|a 26740850
|
| 035 |
|
|
|a (DE-627)DOAJ000151440
|
| 035 |
|
|
|a (DE-599)DOAJc17f44b1d2e142cf9b80430380f3c763
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Frontiers in Drug Delivery
|
| 264 |
3 |
1 |
|b Frontiers Media S.A.
|c 2022-
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 540 |
|
|
|a CC BY
|
| 650 |
|
4 |
|a pharmacology
|
| 650 |
|
4 |
|a basic pharmacology
|
| 650 |
|
4 |
|a clinical pharmacology
|
| 650 |
|
4 |
|a therapeutics
|
| 650 |
|
4 |
|a opthalmology
|
| 650 |
|
4 |
|a molecular targets
|
| 650 |
|
4 |
|a Therapeutics. Pharmacology
|
| 650 |
|
4 |
|a RM1-950
|
| 856 |
4 |
0 |
|u https://doaj.org/toc/2674-0850
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontiersin.org/journals/drug-delivery/
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontiersin.org/journals/drug-delivery/about#about-open
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontiersin.org/guidelines/author-guidelines
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontiersin.org/journals/drug-delivery/about#about-scope
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontiersin.org/about/fee-policy
|x Verlag
|z kostenfrei
|
| 912 |
|
|
|a GBV_DOAJ
|
| 951 |
|
|
|a JT
|
